VEGFA and neoplasm: They promote antigen presentation, activate the tumor immune response, reverse VEGF-induced immunosuppression, promote the migration and infiltration of immune lymphocytes, enhance the activity of T lymphocytes and immune effector molecules, normalize the tumor vascular system, and improve therapeutic drug delivery (Lee WS.